Hepatobiliary & Pancreatic Diseases International
Издатель: Elsevier · ISSN 1499-3872 · 62 статей
- Drain-tract seeding after Whipple resection: A reflection of pancreatic cancer biology
- Fibroblast growth factor 21 analogues in the FDA pipeline: Hope for metabolic dysfunction-associated steatotic liver disease therapy after resmetirom
- Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients
- Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma: Recent developments and insights
- The outcomes of surgical resection versus ablation of liver metastases from neuroendocrine tumors: A systematic review
- Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis
- Machine learning-driven prognostication in liver transplantation: A tacrolimus intrapatient variability enhanced predictive model
- Proximal splenic artery ligation improves liver reperfusion, mitigates graft injury and decreases complications after liver transplantation
- Clinicopathological features and prognosis of dual-phenotype hepatocellular carcinoma after curative hepatectomy: A propensity score matching analysis
- Multiphase enhanced computed tomography features captured by delta radiomics reveal prognosis and tumor heterogeneity in patients with hepatocellular carcinoma treated with transarterial chemoembolization
- Exosomal hnRNPA2B1 suppresses irinotecan-induced ferroptosis in pancreatic cancer
- Cost-effectiveness of ivosidenib in patients with previously treated isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma: An Italian perspective
- The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation
- Biliary adenofibroma: Benign behavior but a potential cholangiocarcinoma
- Ablation of hepatocellular carcinoma at high-risk sites based on nanosecond pulsed electric field
- Conversion therapy with arterial reconstruction: Redefining the resect-ability of locally advanced pancreatic cancer
- Non-physiological renoportal anastomosis during liver transplantation in a patient with Yerdel grade 4 portal vein thrombosis
- Methyl-CpG-binding protein 2 facilitates progression of metabolic dysfunction-associated fatty liver disease via lactylation
- Pancreatic tuberculosis: Likely originating from peripancreatic tuberculous lymphadenitis
- FOLFOX-HAIC versus first-line systemic chemotherapy in HBsAg-positive patients with unresectable intrahepatic cholangiocarcinoma: A propensity score matched cohort study
- Young patients with hepatocellular carcinoma beyond Milan criteria had higher early recurrence and poorer long-term outcomes after hepatectomy
- Development and validation of the APASL score: A laboratory-based prognostic model for survival prediction in patients undergoing hepatectomy for hepatocellular carcinoma
- Metabolic signatures in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma
- Mitogen-activated protein kinase signaling and drug-induced liver injury: A molecular connection
- The feasibility and influencing factor of endoscopic ultrasound-guided tissue acquisition for next-generation sequencing in pancreatic ductal adenocarcinoma patients
- Raman spectral signature uncovers predictive biomarkers for primary graft dysfunction in liver transplant: A proof-of-concept study
- Adenomyomatous hyperplasia of the ampulla of Vater mimicking ampullary carcinoma with elevated tumor indicators in a patient with hepatocellular carcinoma
- Clinical and contrast-enhanced ultrasound features of gallbladder adenosquamous carcinoma: Analysis of 17 cases
- Acute-on-chronic liver failure: Therapeutic challenges managed with bioartificial liver support
- Environmental factors reshaping the etiology of hepatocellular carcinoma: From environmental exposures to molecular mechanisms